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Methods: In 45 patients (pts) with Coronary artery disease (NYHA II or
Ill) undergoing stress echocardiography, QT-peak dispersion (QTPD) and
corrected (Bazeft) QTpaak dispersion (QTPD*) were obtained at rest, and
after DIP. Based on the detection of transient wall motion abnormalities






Results:In R (18 pts) significant differences between rest and DIP were
seen for both QTDDand QTIJD*7while in NR (27 Pte) no significant changes
occurred.Conclusions:Transient ischemia indu&d “by DIP results in a sig-
nificant increased QT-dispersion. Therefore, patients with potential disparity
of ventricular depolarizationmay be identified by DIP.
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m7226 FamilialInfluencesonQTandQTcDispersion
L. Swan, D. Birnie, J. Connell, W.S. Hillis. EJepaflrnentofrWdicirreand
Therapeutics,UniversifyofGlasgowUK
QT and QTc dispersion have been postulated as markers for cardiac death
in aeveral patient groups including those with chronic heaflfailure, peripheral
vascular disease or previous myocardial infarction. Increased QT dispersion
is postulated as representing instability of repolarfsation and therefore a
tendency to arrhythmia. Factors affecting QT dispersion are as yet unclear.
QT and QTc dispersion was examined in a group of 34 paire of same sex
mono- and dizygotic twins to determine tha effect of familial and genetic
factors (mean age 54.1 yrs). 2 painswere exciuded due to bundle branch
block and intake of drugs known to prolong the QT intewal in one twin.
QTDispersion QTc Dispersion
Total Mono- Dizygotic Total Mono- Dizygotic
cohort zygotic cohort zygotic
N 32 18 14 32 Is 14
Intre.paircorrelation 0.5664 0.5543 0.6349 0.5736 0.5807 0,56S1
p value 0.001 0.021 0.015 0.001 0.015 0.027
QT and QTcdispersion corralate highly between twin pairs. There was no
evidence that age influenced QT dispersion (r= -0.15, p = NS) or QTcdis-
persion. These findings suggest familial influences are impaIsmt. However,
the mrrelations were similar in both mono-zygoticand dizygotic subgroups,
thus indicating familial influences may be due to a shared environment rather
than direct genetic factors.











A deletion (D) polymorphism in the ACE gene has been identified as a risk
factor for myocardial infarction (Ml) and the apoE 84 aliele (al) has been
correlated with premature atherosclerosis (ATH). Additional, apoE 82 al has
been attributed a “protective” effect against ATH. We evaluated possibie
differences in ACE and apoE genotype distribution in patients with coronary
artery disease (CAD) in relation to ML
139 oatiants (mean aoe 55 vrs. 85.7% males) with CAD where chosen for
thestudybassd onangiographic criteria. Previous Mi diagnosis was basedon
compiete hospital charts. Lipid profile, Total Cholesterol-TC, Triglycerides-
TG, HDL and Lp (a) was evaluated. ACE and apoE gene polymorphic
fragments were amplified by the polymeraee chain reaction. ACE genotype
was visualissd after direct agarose gel electrophoresis of PCR fragments
while apoE genotype was determined after Hhal digestion of PCR products
and subsequent polyac~lamide gei electrophoresis.
Distribution of apoE and ACE (D/1)genotypes between the 2 groups of
patients (88 pts with and 71 pts without Ml) are summarized:
apoE allele N =66 N =71 Total D/l sllele N =66 N =71 Total
(“Afra- Ml(+) Ml(-) 139 pta (% fre- Ml(+) Ml(–) 139 pta
quency) (%) (“/0) (%) quency) (%) (%) (%)
&2 0.7 6.3 3.6 D 61.0 55.6 5s.3
&3 67.5 57.3 57.4 I 39.0 44.4 41,7
64 11.s 6.3 9.0 P = n.a,
X2 = S.34, df = 2, P = 0.015
The significant decrease in S2al frequency, among patients with Mi is par-
alleled by an almost equal increaee in 84 al frequency, while the frequency of
e3 al remains unchanged. No difference in DA al frequencies was observed
in relation to Ml. The same applies to the comparison between CAD patients
and 25 age and sex matched mntrols (D/1frequency % 58.3/41.7 in patients
vs 58.5/43.5 in controls). TC and LDL-C levels did not reach statistical sig-
nificance. In conclusion, although ACE polymorphism is intensively studied
as predisposing to Ml, in our study apolipoprotein-E gene polymorphism was
found to be more important.
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HeartDweaaeThanPlaamaLp(a)
KM. Kostner, G. Maurer, T. Stefenelii, K. Huber. UniversifyotVienrra,
Austria
Increased plasma Lp(a) levels are strongly associated with premature cardio-
vascular disease and stroke. Since Lp(a) immune reactivity is found in urine,
we compared urinary ape(a) with plasma Lp(a) levels in 118patients suffering
fmm angiographieeily proven coronary artery disease with those of 109 con-
trols. Urinary ape(a), investigated by immuno blotting, consistencyrevealed
a very distirtef ape(a) fragmentation pattern with molecular weights belween
30-180 kD. Apoli~proteinB, however, was not detected in urine. Lp(a) and
ape(a) were measured by a fh.IOF3SCenC0 immuno assay (DELFIA). Within
single individuals, urinary ape(a) levels correlated significantly with creatinine
(Rho = 0.98; p c 0.0005). Medians and 25/75 pemantiies of urinary ape(a) in
CAD patients were 5.70,3.25 and 10.35 @dl and in controls 2.64, 1.43 and
3.50 #g/all, respectively. At cut-off levels of 30 mg/dl for plasma Lp(a) and
10 Kg/all for urinary ape(a) concentration both parameters had the same
sensitivity (29.3% vs. 32.8%), yet the specificity (90.8% vs. 78.4%) and the
positive predictive value of urina~ ape(a) were much higher. Urinaty secre-
tion of ape(a) fragments normalized tocreatinine is stable inagiven individual
and significantly associated with coronary artery disease. It has a higher dis-
criminative power than plasma Lp(a). Our results provide the baais for larger
studiea assessing the role of Lp(a) in cardiovascular disease and stroke.
4:30
n7233 ACEGenePolymorphismin PatientsWithFamiliarHvBercholesterolemia:ComparisonWithInfarct.. ,.
PstientsandHeelthyControls
S. Ahnve, G. Eggerteen, T. Flodin, M. Erikason. Deptof Cardiobgyj1Dept
of C/inChem,HuddingeUniversityHospital,Stockholm,Sweden
A marker of the ACE gene has been related to myocardial infarction (Ml),
cardiomyopathy and circulating ACE activity. Different ACE gene mutations
has not been evaluated in patients with familial hypercholesterolemia (FH).
We have evaluated a large number (n = 157) heterozygous FH patients and
256 consecutive acute Ml patients as well as 420 healthy normals. No age
limits were used, the mean age of the FH patients was 52.5 + 14.3 yrs, for
infarct patients 68.9 + 12.1 yrs and for normals 44.5 + 18.7 yrs. Genotyping
of ACE was performed using PCR technique.
Results:
ACE genotype All Women
FH AMI N FH AMI N
n 157 250 420 157 250 420
II% 24 22 24 24 24 24
ID% 45 46 51 39 39 54
DD “k 31 32 25 37 37 22
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